Dennison “Dan” T. Veru
Chief Investment Officer
Mr. Veru serves as Palisade’s Chief Investment Officer, and is a member of the Firm’s Investment Policy Committee. In this capacity, he has oversight responsibilities for all of Palisade’s investment strategies that trade publicly traded securities. Mr. Veru is a member of the Board of Directors of Brickell Biotech, Inc. and BioCancell Ltd., each of which are portfolio companies owned by private equity funds managed by the Firm. Mr. Veru became associated with Palisade’s partners in 1984 at Drexel Burnham Lambert and later at Smith Barney, where he held a variety of analytical positions. From 1992 through 1999, he was President and Director of Research at Awad Asset Management, a division of Raymond James & Associates. Mr. Veru rejoined his colleagues at Palisade in 2000 as Chief Investment Officer. A graduate of Franklin & Marshall College, Mr. Veru has appeared as a guest on CNBC, Bloomberg News, and Fox Business News. He also contributes market opinions to various financial publications.